We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Basilea Pharmaceutica Ag | LSE:0QNA | London | Ordinary Share | CH0011432447 | BASILEA PHARMACEUTICA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 46.20 | 45.05 | 47.35 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 150.28M | 10.45M | 0.8708 | 55.29 | 577.9M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/6/2024 | 06:15 | UKREG | Basilea verpartnert Onkologie-Wirkstoffkandidat Lisavanbulin mit.. |
| 20/6/2024 | 06:15 | UKREG | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma.. |
| 16/5/2024 | 06:15 | UKREG | Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und.. |
| 16/5/2024 | 06:15 | UKREG | Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and.. |
| 03/5/2024 | 06:15 | UKREG | Basilea reports presentation of new data for ceftobiprole (Zevtera®) at.. |
| 03/5/2024 | 06:15 | UKREG | Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®).. |
| 24/4/2024 | 17:00 | UKREG | Basilea shareholders approve all proposals of the board of directors at the.. |
| 24/4/2024 | 17:00 | UKREG | Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des.. |
| 09/4/2024 | 06:15 | UKREG | Basilea awarded CARB-X grant to develop recently acquired novel class of.. |
| 09/4/2024 | 06:15 | UKREG | Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich.. |
1 Year Basilea Pharmaceutica Chart |
Intraday Basilea Pharmaceutica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
